The VICC.ORG Directory of Doctors, Healthcare Providers & Researchers
John A. Phillips, M.D.
Professor of Pediatrics, Biochemistry, Medicine, and Pathology
VICC Member
Researcher
Contact Information:
Vanderbilt University Medical Center
DD-2205 Medical Center North
Nashville, TN 37232-2578
615-322-7601
Education
- M.D. - Wake Forest University, 1969
- Fellowship - Johns Hopkins Hospital and Health System, 1974
- Residency - Boston Children's Hospital, 1972
- Internship - Boston Children's Hospital, 1970
Research Specialty
Molecular investigations of familial disorders
Research Description
My current research interests are molecular investigations of the pathogenesis of Mendelian disorders. These include specific studies of the following: 1) genetic defects in the growth hormone (GH) synthetic pathway and regulation of alternative splicing of GH1 transcripts, 2) genetic basis of familial primary pulmonary hypertension (FPPH), 3) genetic basis of familial dyslexia, 4) genetic basis of idiopathic pulmonary fibrosis (IPF) and 5) determining the molecular basis of VLCAD, LCHAD and other selected disorders of fatty acid oxidation and genes that metabolize medications using a new patented method (GVS) to screen for human genome variation.
Studies of familial defects of the GH synthetic pathway include analysis of the GH, GH releasing hormone receptor (GHRHR) and pituitary speciufic transcription factor (PROP1) genes in kindreds with defects in GH biosynthesis or action. These studies have investigated the contribution of GH, GHRHR and PROP1 defects to familial forms of isolated GH and multiple pituitary hormone deficiencies. Present studies of alternative splicing of GH1 transcripts have identified dual exon and intron splice enhancers (ESE and ISEs) that regulate alternative splicing to select use of weak splicing sequences to achieve constitutive splicing patterns. We have identified a series of splicing enhancer mutations that perturb alternative splicing of GH transcripts to cause Mendelian forms of GH deficiency. The interactions between these enhancers and SR proteins to achieve tissue specific regulationof normal splicing patterns is being studied to determine the basic mechanisms that regulate alternative splicing. Parallel, collaborative sutdies of transgenic mice to determine the pathogenic mechanism by which alternative GH1 transcript splicing causes pituitary cell death.
Studies of FPPH include our mapping the gene for FPPH and discovery of BMPR2 mutations that cause FPPH. We have determined the mechanisms by which heterogeneous BMPR2 mutations cuase FPPH. We are now determining the contributions of BMPR2 and modifer gene mutations to the reduced penetrance that is observed in FPPH.
Studies of idiopathic pulmonary fibrosis or IPF have led to our discovery that heterozygosity for a surfactant protein C (SFTPC) mutation causes familial usual interstitial pneuomonitis in adults and cellular interstitial pneumonitis in children. These diagnoses represent pleiotropic effects of the retained protein that results from the SFTPC mutation that segregates in these large kindred. We are now determining the proportion of IPF families that are caused by SFTPC as well as the role of environmental agents in triggering IPF.
Studies of VLCAD and LCHAD include our devising PCR primers that will amplify the entire or combined segments of these genes. We are now applying a new, patented method of genetic variation screening (genomic variation screening or GVS) to detect all mutations that occur in the alleles of individuals who have these familial disorders of fatty oxidation.
We are also using GVS to screen genes that metabolize many medications and xenobiotics for common variations that occur in different populations. The common variations that we will find are likely to contribute to variations between the responses of different individuals to medications and environmental factors.
Publications
- Patton, JG, Phillips, JA III, Ryther, RC "Targeted Degradation of RNA. United States Provisional Patent Application # 60/516,391." , Nov 26, 2003.
- Lane, KB, Blackwell, TR, Runo, J, Wheeler, L, Phillips, JA, Loyd, JE Aberrant signal transduction in pulmonary hypertension. Chest, 128(6 Suppl), 564S-565S, 2005.
- Garland, EM, Winker, R, Williams, SM, Jiang, L, Stanton, K, Byrne, DW, Biaggioni, I, Cascorbi, I, Phillips, JA, Harris, PA, Rüdiger, H, Robertson, D Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension, 46(5), 1103-10, 2005.
- Cogan, JD, Vnencak-Jones, CL, Phillips, JA, Lane, KB, Wheeler, LA, Robbins, IM, Garrison, G, Hedges, LK, Loyd, JE Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med, 7(3), 169-74, 2005.
- Cogan, J.D., Vnencak-Jones, C.L., Phillips, J.A. III, Lane, K.B., Wheeler, L.A., Robbins, I.M., Garrison, G., Ledges, L.K. and Loyd, J.E "Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension." Genetics in Medicine , 7169-174, 2005.
- Ryther, RCC, Flynt, AS, Phillips, JA III, and Patton, JG "siRNA therapeutics: big potential from small RNAs." Gene Therapy , 125-11, 2005.
- Ryther, RC, Flynt, AS, Phillips, JA, Patton, JG siRNA therapeutics: big potential from small RNAs. Gene Ther, 12(1), 5-11, 2005.
- Ryther, Robin C. C., Flynt, Alex S., Harris, Bryan D., Phillips, John A., Patton, James G. GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific siRNA. Endocrinology, 2004.
- Newman, JH, Trembath, RC, Morse, JA, Grunig, E, Loyd, JE, Adnot, S, Coccolo, F, Ventura, C, Phillips, JA, Knowles, JA, Janssen, B, Eickelberg, O, Eddahibi, S, Herve, P, Nichols, WC, Elliott, G Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol, 43(12 Suppl S), 33S-39S, 2004.
- Lawson, WE, Grant, SW, Ambrosini, V, Womble, KE, Dawson, EP, Lane, KB, Markin, C, Renzoni, E, Lympany, P, Thomas, AQ, Roldan, J, Scott, TA, Blackwell, TS, Phillips, JA, Loyd, JE, du Bois, RM Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax, 59(11), 977-80, 2004.
- Phillips, JA Genetics of growth retardation. J Pediatr Endocrinol Metab, 17 Suppl 3385-99, 2004.
- Williams, SM, Ritchie, MD, Phillips, JA, Dawson, E, Prince, M, Dzhura, E, Willis, A, Semenya, A, Summar, M, White, BC, Addy, JH, Kpodonu, J, Wong, LJ, Felder, RA, Jose, PA, Moore, JH Multilocus analysis of hypertension: a hierarchical approach. Hum Hered, 57(1), 28-38, 2004.
- Williams, SM, Ritchie, MD, Phillips, JA III, Dawson, E, Prince, M, Dzhura, E, Willis, A, Semenya, A, Summar, M, White, BC, Addy, JH, Kpodonu, J, Wong, L-J, Felder, RA and Moore, JH "Multilocus analysis of hypertension: a hierarchical approach to a complex problem." Hum Hered , 5728-38, 2004.
- Hunley, TE, Corzo, D, Dudek, M, Kishnani, P, Amalfitano, A, Chen, YT, Richards, SM, Phillips, JA, Fogo, AB, Tiller, GE Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease. Pediatrics, 114(4), e532-5, 2004.
- Potter, A, Hannig, V, Phillips, JA The role of genetics in pediatric endocrinology. Pediatr Endocrinol Rev, 1(3), 262-73, 2004.
- McGuinness, L, Magoulas, C, Sesay, AK, Mathers, K, Carmignac, D, Manneville, J-B, Christian, H, Phillips, J.A. III and Robinson, I.C.A.F "Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice.." Endocrinol, 144720-731, 2003.
- Ryther, Robin C C, McGuinness, Lindsay M, Phillips, John A, Moseley, Chanda T, Magoulas, Charalambos B, Robinson, Iain C A F, Patton, James G Disruption of exon definition produces a dominant-negative growth hormone isoform that causes somatotroph death and IGHD II. Hum Genet, 113(2), 140-8, 2003.
- Phillips, John A Dominant-negative diabetes insipidus and other endocrinopathies. J Clin Invest, 112(11), 1641-3, 2003.
- Runo, James R, Vnencak-Jones, Cindy L, Prince, Melissa, Loyd, James E, Wheeler, Lisa, Robbins, Ivan M, Lane, Kirk B, Newman, John H, Johnson, Joyce, Nichols, William C, Phillips, John A Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med, 167(6), 889-94, 2003.
- Thomas, Alan Q, Carneal, Jennifer, Markin, Cheryl, Lane, Kirk B, Phillips, John A, Loyd, James E Allelic imbalance demonstrated by microsatellite analysis of lung samples from patients with familial pulmonary fibrosis. Chest, 121(3 Suppl), 25S, 2002.
- Moseley, Chanda T, Mullis, Primus E, Prince, Melissa A, Phillips, John A An exon splice enhancer mutation causes autosomal dominant GH deficiency. J Clin Endocrinol Metab, 87(2), 847-52, 2002.
- Moseley, CT, Mullis, PE, Prince, MA and Phillips & JA III "An exon splice enhancer mutation causes autosomal dominant growth hormone deficiency." J. Clin. Endocrinol. Metab., 87(J.Clin.Endocrinol. Metab.), 847-852, 2002.
- Moseley, Chanda T, Orenstein, Matthew D, Phillips, John A GH Gene Deletions and IGHD type IA. Rev Endocr Metab Disord, 3(4), 339-46, 2002.
- Thomas, AQ, Lane, K, Phillips, JA III, Prince, M., Markin, C, Gaddipati, R, Marney, A, Johnson, J, Haines, J, Stahlman, M and Loyd, JE "Heterozygosity for a surfactant protein C mutation causes familial usual interstitial pneuomonitis in adults and cellular interstitial pneumonitis in children." Am J Respir Crit Care Med , 1651322-1328, 2002.
- Luka, Zigmund, Cerone, Roberto, Phillips, John A, Mudd, Harvey S, Wagner, Conrad Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism. Hum Genet, 110(1), 68-74, 2002.
- Phillips, John A Mutations of the GH gene. J Pediatr Endocrinol Metab, 15 Suppl 51435-6, 2002.
- Thomas, Alan Q, Carneal, Jennifer, Markin, Cheryl, Lane, Kirk B, Phillips, John A, Loyd, James E, Gaddipati, Radhika Specific bone morphogenic protein receptor II mutations found in primary pulmonary hypertension cause different biochemical phenotypes in vitro. Chest, 121(3 Suppl), 83S, 2002.
- Machado, R.D., Pauciulo, M.W., Thomson, J.R., Lane, K.B., Morgan, N.V., Wheeler, L., Phillips, J.A. III, Newman, J., Williams, D., Galie, N., Manes, A., McNeil, K., Yacoub, M., Mikhail, G., Rogers, P., Corris, P., Humbert, M., Donnai, D., Martensson, G., Tranebjaerg, L., Loyd, J.E., Trembath, R.C. and Nichols, W.C "BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension." Am. J. Hum. Genet., 6892-102, 2001.
- Marney, A, Lane, K B, Phillips, J A, Riley, D J, Loyd, J E Idiopathic pulmonary fibrosis can be an autosomal dominant trait in some families. Chest, 120(1 Suppl), 56S, 2001.
- Salvatori, R., Fan, X., Phillips, J.A. III, Prince, M. and Levine, M.A "Isolated growth hormone (GH) deficiency due to compound heterozygosity for two new mutations in the GH-releasing hormone receptor gene." Clin. Endocrinol., 54681-687, 2001.
- Dawson, E.T. and Phillips, J.A. III "Method for determining polynucleotide sequence variations." United States Patent # 6, 322,988 B1, Nov 27, 2001.
- Newman, J H, Wheeler, L, Lane, K B, Loyd, E, Gaddipati, R, Phillips, J A, Loyd, J E Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med, 345(5), 319-24, 2001.
- Newman, J.H., Wheeler, L., Lane, K.B., Loyd, E., Gaddipati, R., Phillips, J.A. III and Loyd, J.E "Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred." N. Engl. J. Med., 345319-324, 2001.
- Amalfitano, A., Bengur, A.R., Morse, R.P., Majure, J.M., Case, L.E., Veerling, D.L., Mackey, J., Kishnani, P., Smith, W., McVie-Wylie, A., Sullivan, J.A., hoganson, G.E., Phillips, J.A. III, Schaefer, G.B., Charrow, J., Ware, R.E., Bossen, E.H. and Chen, Y.-T "Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial." Genetics in Medicine , 3132-138, 2001.
- Salvatori, R., Fan, X., Phillips, J.A. III, Espigares-Martin, R., de Lara, I.M., Freeman, K.L., Plotnick, L., Al-Ashwal, A. and Levine, M.A "Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type IB." J. Clin. Endocrinol. Metab., 86273-279, 2001.
- Phillips, J A msJAMA. Genomic medicine: managing the complexity. JAMA, 286(13), 1639, 2001.
- Skordis, N, Patsalis, P C, Hettinger, J A, Kontou, M, Herakleous, E, Krishnamani, M R, Phillips, J A A novel arginine vasopressin-neurophysin II mutation causes autosomal dominant neurohypophyseal diabetes insipidus and morphologic pituitary changes.. Horm Res, 53(5), 239-45, 2000.
- Williams, S.M., Addy, J.H., Phillips, J.A. III, Dai, M., Kpodonu, J., Afful, J., Jackson, H., Joseph, K., Eason, F., Murray, M.M., Epperson, P., Aduonum, A., Wong, L.-J., Jose, P.A. and Felder, R.A "Combinations of variations in multiple genes are associated with hypertension." Hypertension, 362-6, 2000.
- The International PPH Consortium K. B. Lane, R. Machado, M. W. Pauciulo, J. R.Thomson, J. A. Philips III, J. E. Loyd, W C. Nichols and R C. Trembath "Heterozygous Germline mutations in BMPR-II are the cause of Familial Primary Pulmonary Hypertension." Nature Genetics , 2681-84, 2000.
- Lane, K B, Machado, R D, Pauciulo, M W, Thomson, J R, Phillips, J A, Loyd, J E, Nichols, W C, Trembath, R C Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet, 26(1), 81-4, 2000.
- Cogan, J.D. and Phillips, J.A. III "Inherited defects in growth hormone synthesis and action." The Metabolic and Molecular Bases of Inherited Disease, Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. (eds), 8th edition, McGraw-Hill, 4159-4180, 2000.
- Moseley, C T, Phillips, J A Pituitary gene mutations and the growth hormone pathway. Semin Reprod Med, 18(1), 21-9, 2000.
- Phillips, J A, Prince, M A Applications of new genetic approaches to growth hormone-releasing hormone receptor defects. Growth Horm IGF Res, 9 Suppl A45-9, 1999.
- Salvatori, R., Gondo, R.G., de Aguirar Oliveira, M.H., Phillips, J. A. III, Souza, A.H., Hayashida, C.Y., Toledo, S.P., Conceicao, M.M., Prince, M., Baumann, G. and Levine, M.A "Familial isolated growth hormone deficiency due to a novel mutation in the growth hormone-releasing hormone receptor." J. Clin. Endocrinol. Metab., 84917-923, 1999.
- Raskin, S, Phillips, J A, Kaplan, G, McClure, M, Vnencak-Jones, C, Rozov, T, Cardieri, J M, Marostica, P, Abreu, F, Giugliani, R, Reis, F, Rosario, N A, Ludwig, N, Pereira, L, Faucz, F, Gabardo, J, Culpi, L Geographic heterogeneity of 4 common worldwide cystic fibrosis non-DF508 mutations in Brazil. Hum Biol, 71(1), 111-21, 1999.
- Phillips, J A, Hamid, R Human mutations and their detection by gene and linkage analysis, allele sharing and association methods. East Mediterr Health J, 5(6), 1140-6, 1999.
- Fuller, B.P., Kahn, M.J.E., Barr, P.A., Biesecker, L., Crowley, E., Garber, J., Mansoura, M.K., Murphy, P., Murray, J., Phillips, J., Rothenberg, K., Rothstein, M., Stopfer, J., Swergold, G., Weber, B., Collins, F.S. and Hudson, K.L "Privacy in genetics research." Science , 2851359-1361, 1999.
- Nishimura, H, Yerkes, E, Hohenfellner, K, Miyazaki, Y, Ma, J, Hunley, TE, Yoshida, H, Ichiki, T, Threadgill, D, Phillips, JA III, Hogan, BML, Fogo, A, Brock, JW III, Inagami, T and Ichikawa, I "Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men." Molec. Cell , 31-10, 1999.
- Nishimura, H, Yerkes, E, Hohenfellner, K, Miyazaki, Y, Ma, J, Hunley, T E, Yoshida, H, Ichiki, T, Threadgill, D, Phillips, J A, Hogan, B M, Fogo, A, Brock, J W, Inagami, T, Ichikawa, I Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell, 3(1), 1-10, 1999.
- McCarthy, E.M.S. and Phillips, J.A. III "Characterization of an intron splice enhancer that regulates alternative splicing of GH pre-mRNA." Human Molec. Genetics , 71491-1496, 1998.
- McCarthy, E M, Phillips, J A Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA.. Hum Mol Genet, 7(9), 1491-6, 1998.
- Cogan, J D, Phillips, J A Growth disorders caused by genetic defects in the growth hormone pathway. Adv Pediatr, 45337-61, 1998.
- Dasouki, M J, Cogan, J, Summar, M L, Neblitt, W, Foroud, T, Koller, D, Phillips, J A Heterogeneity in hereditary pancreatitis. Am J Med Genet, 77(1), 47-53, 1998.
- Wu, W., Cogan, J.D., Pfaffie, R.W., Dasen, J.S., Frisch, H., O'Connell, S.M., Flynn, S.E., Brown, M.R., Mullis, P.E., Parks, J.S., Phillips, J.A. III and Rosenfeld, M.G "Mutations in PROP1 cause familial combined pituitary hormone deficiency." Nature Genetics , 18147-149, 1998.
- Cogan, J D, Wu, W, Phillips, J A, Arnhold, I J, Agapito, A, Fofanova, O V, Osorio, M G, Bircan, I, Moreno, A, Mendonca, B B The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab, 83(9), 3346-9, 1998.
- Cogan, J.D., Wu, W., Phillips, J.A. III, Arnhold, I.J.P., Agapito, A., Fofanova, O.V., Osorio, M.G.F., Bircan, I., Moreno, A. and Mendonca, B.B "The PROP1 2-bp deletion is a common cause of CPHD." J. Clin. Endocrinol. & Metab., 833346-3349, 1998.
- Cogan, J.D., Prince, M.A., Lekhakula, S., Bundey, S., Futrakul, A., McCarthy, E.M.S. and Phillips, J.A. III "A novel mechanism of aberrant pre-mRNA splicing in humans." Hum. Molec. Genet., 6909-912, 1997.
- Cogan, J D, Prince, M A, Lekhakula, S, Bundey, S, Futrakul, A, McCarthy, E M, Phillips, J A A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet, 6(6), 909-12, 1997.
- Raskin, S, Phillips, J A, Krishnamani, M R, Vnencak-Jones, C, Parker, R A, Rozov, T, Cardieri, J M, Marostica, P, Abreu, F, Giugliani, R, Reis, F, Rosario, N A, Ludwig, N, Culpi, L Cystic fibrosis in the Brazilian population: DF508 mutation and KM-19/XV-2C haplotype distribution. Hum Biol, 69(4), 499-508, 1997.
- Miyata, I, Cogan, J D, Prince, M A, Kamijo, T, Ogawa, M, Phillips, J A Detection of growth hormone gene defects by dideoxy fingerprinting (ddF). Endocr J, 44(1), 149-54, 1997.
- Dasouki, M, Jurecic, V, Phillips, J A, Whitlock, J A, Baldini, A DiGeorge anomaly and chromosome 10p deletions: one or two loci. Am J Med Genet, 73(1), 72-5, 1997.
- Endsley, J K, Phillips, J A, Hruska, K A, Denneberg, T, Carlson, J, George, A L Genomic organization of a human cystine transporter gene (SLC3A1) and identification of novel mutations causing cystinuria. Kidney Int, 51(6), 1893-9, 1997.
- Repaske, D.R., Medlej, R., Gultekin, E.K., Krishnamani, M.R.S., Halaby, G., Findling, J.W. and Phillips, J.A.III "Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-'-Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptide precursor." J. Clin. Endocrinol. Metab, 8251-56, 1997.
- Nichols, W.C., Koller, D.L., Slovis, B., Foroud, T., Terry, V.H., Arnold, N.D., Siemieniak, D.R., Wheeler, L., Phillips, J.A. 111, Newman, J.H., Conneally, P.M., Ginsburg, D. and Loyd, J.E "Localization of the gene for familial primary pulmonary hypertension to chromosome 2q3l-32." Nature Genetics , 15277-280, 1997.
- Williams, J B, Rexer, B, Sirripurapu, S, John, S, Goldstein, R, Phillips, J A, Haley, L L, Sait, S N, Shows, T B, Smith, C M, Gerhard, D S The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome. Genomics, 42(2), 325-30, 1997.
- Loyd, J E, Slovis, B, Phillips, J A, Butler, M G, Foroud, T M, Conneally, P M, Newman, J H The presence of genetic anticipation suggests that the molecular basis of familial primary pulmonary hypertension may be trinucleotide repeat expansion. Chest, 111(6 Suppl), 82S-83S, 1997.
- Hunley, T E, Julian, B A, Phillips, J A, Summar, M L, Yoshida, H, Horn, R G, Brown, N J, Fogo, A, Ichikawa, I, Kon, V Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int, 49(2), 571-7, 1996.
- Hunley, T.E., Julian, B.A., Phillips, J.A. III, Summar, M.L., Yoshida, H., Horn, R.G., Brown, N.J., Fogo, A., Ichikawa, I. and Kon, V "Angiotensin converting enzyme, but not angiotensinogen or angiotensin type 1 receptor, gene poly-morphism predict progressive renal damage in IgA nephropathy." Kidney International , 49571-77, 1996.
- Sierra-Rivera, E, Dasouki, M, Summar, M L, Krishnamani, M R, Meredith, M, Rao, P N, Phillips, J A, Freeman, M L Assignment of the human gene (GLCLR) that encodes the regulatory subunit of gamma-glutamylcysteine synthetase to chromosome 1p21. Cytogenet Cell Genet, 72(2-3), 252-4, 1996.
- Raskin, S, Cogan, J D, Summar, M L, Moreno, A, Krishnamani, M R, Phillips, J A Genetic mapping of the human pituitary-specific transcriptional factor gene and its analysis in familial panhypopituitary dwarfism.. Hum Genet, 98(6), 703-5, 1996.
- Hill, K E, Dasouki, M, Phillips, J A, Burk, R F Human selenoprotein P gene maps to 5q31. Genomics, 36(3), 550-1, 1996.
- Clayton, E W, Hannig, V L, Pfotenhauer, J P, Parker, R A, Campbell, P W, Phillips, J A Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet, 58(3), 617-27, 1996.
- Cogan, J.D., Ramel, B., Lehto, M., Phillips, J.A. III, Prince, M., Blizzard, M., deRavel, T.J.L., Brammert, M. and Groop, L "A recurring dominant-negative mutation causes autosomal dominant growth hormone deficiency." J. Clin. Endocrinol. & Metab, 803591-3595, 1995.
- Sierra-Rivera, E, Summar, M L, Dasouki, M, Krishnamani, M R, Phillips, J A, Freeman, M L Assignment of the gene (GLCLC) that encodes the heavy subunit of gamma-glutamylcysteine synthetase to human chromosome 6. Cytogenet Cell Genet, 70(3-4), 278-9, 1995.
- Campbell, P W, Phillips, J A, Heidecker, G J, Krishnamani, M R, Zahorchak, R, Stull, T L Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol, 20(1), 44-9, 1995.
- Loyd, J E, Butler, M G, Foroud, T M, Conneally, P M, Phillips, J A, Newman, J H Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med, 152(1), 93-7, 1995.
- Ardehali, H, Printz, R L, Koch, S, Phillips, J A, Granner, D K Isolation, characterization and chromosomal localization of a human pseudogene for hexokinase II. Gene, 164(2), 357-61, 1995.
- Summar, M L, Dasouki, M J, Schofield, P J, Krishnamani, M R, Vnencak-Jones, C, Tuchman, M, Mao, J, Phillips, J A Physical and linkage mapping of human carbamyl phosphate synthetase I (CPS1) and reassignment from 2p to 2q35. Cytogenet Cell Genet, 71(3), 266-7, 1995.
- Clayton, E W, Hannig, V L, Pfotenhauer, J P, Parker, R A, Campbell, P W, Phillips, J A Teaching about cystic fibrosis carrier screening by using written and video information. Am J Hum Genet, 57(1), 171-81, 1995.
- Yoshida, H, Kakuchi, J, Yoshikawa, N, Saruta, T, Inagami, T, Phillips, J A, Ichikawa, I Angiotensin II type 1 receptor gene abnormality in a patient with Bartter's syndrome. Kidney Int, 46(6), 1505-9, 1994.
- Phillips, J A DNA mapping in growth and developmental disorders. Horm Res, 41(5-6), 157-68, 1994.
- Cogan, J D, Phillips, J A, Schenkman, S S, Milner, R D, Sakati, N Familial growth hormone deficiency: a model of dominant and recessive mutations affecting a monomeric protein.. J Clin Endocrinol Metab, 79(5), 1261-5, 1994.
- Phillips, J A, Cogan, J D Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. J Clin Endocrinol Metab, 78(1), 11-6, 1994.
- Pérez Jurado, L A, Phillips, J A, Summar, M L, Mao, J, Weber, J L, Schaefer, F V, Hazan, J, Argente, J Genetic mapping of the human growth hormone-releasing factor gene (GHRF) using two intragenic polymorphisms detected by PCR amplification. Genomics, 20(1), 132-4, 1994.
- Parker, R A, Phillips, J A Population screening for carrier status: effects of test limitations on precision of carrier prevalence rates. Am J Med Genet, 49(3), 317-22, 1994.
- Raskin, S, Phillips, J A, Krishnamani, M R, Vnencak-Jones, C, Parker, R A, Rozov, T, Cardieri, J M, Marostica, P, Abreu, F, Giugliani, R DNA analysis of cystic fibrosis in Brazil by direct PCR amplification from Guthrie cards. Am J Med Genet, 46(6), 665-9, 1993.
- Krishnamani, M R, Phillips, J A, Copeland, K C Detection of a novel arginine vasopressin defect by dideoxy fingerprinting. J Clin Endocrinol Metab, 77(3), 596-8, 1993.
- Cogan, J D, Phillips, J A, Sakati, N, Frisch, H, Schober, E, Milner, R D Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J Clin Endocrinol Metab, 76(5), 1224-8, 1993.
- Campbell, P W, Parker, R A, Roberts, B T, Krishnamani, M R, Phillips, J A Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr, 120(2 Pt 1), 261-4, 1992.
- Raskin, S, Phillips, J A, Kaplan, G, McClure, M, Vnencak-Jones, C Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. PCR Methods Appl, 2(2), 154-6, 1992.
- Kamijo, T, Phillips, J A Detection of molecular heterogeneity in GH-1 gene deletions by analysis of polymerase chain reaction amplification products. J Clin Endocrinol Metab, 74(4), 786-9, 1992.
- Phillips, J A Molecular biology of growth hormone receptor dysfunction. Acta Paediatr Suppl, 383127-31, 1992.
- Campbell, P W, Phillips, J A The cystic fibrosis gene and relationships to clinical status. Semin Respir Infect, 7(3), 150-7, 1992.
- Raskin, S, Phillips, J A, Vnencak-Jones, C, Dawson, E, Kaplan, G, McClure, M Utility of internal markers to improve the accuracy of cystic fibrosis genotype analysis. Biotechniques, 13(3), 372-4, 1992.
- Hannig, V L, Erickson, S M, Phillips, J A Utilization and evaluation of living-related donors for patients with adult polycystic kidney disease. Am J Med Genet, 44(4), 409-12, 1992.
- Campbell, P W, Phillips, J A, Krishnamani, M R, Maness, K J, Hazinski, T A Cystic fibrosis: relationship between clinical status and F508 deletion. J Pediatr, 118(2), 239-41, 1991.
- Wampler, G L, Ahlgren, J D, Lokich, J J, Gullo, J J, Phillips, J A Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP study.. Am J Clin Oncol, 14(5), 442-5, 1991.
- Robertson, D, Haile, V, Perry, S E, Robertson, R M, Phillips, J A, Biaggioni, I Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension, 18(1), 1-8, 1991.
- Perry, S E, Phillips, J A, Robertson, D FnuD II RFLP at the human dopamine-beta-hydroxylase (D beta H) locus. Nucleic Acids Res, 19(5), 1162, 1991.
- Perry, S E, Summar, M L, Phillips, J A, Robertson, D Linkage analysis of the human dopamine beta-hydroxylase gene. Genomics, 10(2), 493-5, 1991.
- Hannig, V L, Phillips, J A Maternal cocaine abuse and fetal anomalies: evidence for teratogenic effects of cocaine. South Med J, 84(4), 498-9, 1991.
- Hannig, V L, Hopkins, J R, Johnson, H K, Phillips, J A, Reeders, S T Presymptomatic testing for adult onset polycystic kidney disease in at-risk kidney transplant donors. Am J Med Genet, 40(4), 425-8, 1991.
- Kamijo, T, Phillips, J A, Ogawa, M, Yuan, L, Shi, Y, Bao, X L Screening for growth hormone gene deletions in patients with isolated growth hormone deficiency. J Pediatr, 118(2), 245-8, 1991.
- Ulm, J E, Shah, D M, Dev, V G, Phillips, J A Counseling and decision dilemmas associated with fetal blood sampling. Am J Med Genet, 35(1), 75-8, 1990.
- Phillips, J A Diagnosis at the bedside by gene analysis. South Med J, 83(8), 868-75, 1990.
- Vnencak-Jones, C L, Phillips, J A Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. Science, 250(4988), 1745-8, 1990.
- Summar, M L, Phillips, J A, Battey, J, Castiglione, C M, Kidd, K K, Maness, K J, Weiffenbach, B, Gravius, T C Linkage relationships of human arginine vasopressin-neurophysin-II and oxytocin-neurophysin-I to prodynorphin and other loci on chromosome 20. Mol Endocrinol, 4(6), 947-50, 1990.
- Vnencak-Jones, C.L. and Phillips, J.A. III "Non Alu sequences constitute hot spots for human growth hormone gene deletions." Science, 2501745-1748, 1990.
- Vnencak-Jones, C L, Phillips, J A, Wang, D F Use of polymerase chain reaction in detection of growth hormone gene deletions. J Clin Endocrinol Metab, 70(6), 1550-3, 1990.
- Fenichel, G M, Phillips, J A Familial aplasia of the cerebellar vermis. Possible X-linked dominant inheritance. Arch Neurol, 46(5), 582-3, 1989.
- Phillips, J A, Vnencak-Jones, C L Genetics of growth hormone and its disorders. Adv Hum Genet, 18305-63, 1989.
- Whitlock, J A, Janco, R L, Phillips, J A Inherited hypercoagulable states in children.. Am J Pediatr Hematol Oncol, 11(2), 170-3, 1989.
- Summar, M L, Phillips, J A, Krishnamani, M R, Keefer, J, Trofatter, J, Schwartz, R C, Tsipouras, P, Willard, H, Ullrich, A Protein kinase C: a new linkage marker for growth hormone and for COL1A1. Genomics, 5(1), 163-5, 1989.
- Vnencak-Jones, C L, Phillips, J A, Chen, E Y, Seeburg, P H Molecular basis of human growth hormone gene deletions. Proc Natl Acad Sci U S A, 85(15), 5615-9, 1988.
- Phillips, J A, Hoult, J R Secretory effects of kinins on colonic epithelium in relation to prostaglandins released from cells of the lamina propria.. Br J Pharmacol, 95(3), 701-12, 1988.
- Butler, M G, Fogo, A B, Fuchs, D A, Collins, F S, Dev, V G, Phillips, J A Two patients with ring chromosome 15 syndrome. Am J Med Genet, 29(1), 149-54, 1988.
- Repaske, D R, Phillips, J A Application of molecular genetics to pediatric gynecology. Clin Obstet Gynecol, 30(3), 762-75, 1987.
- Phillips, J A Gene diagnosis: detection of genetic disorders by DNA analysis. Birth Defects Orig Artic Ser, 23(3), 259-95, 1987.
- Kazazian, H H, Phillips, J A, Boehm, C D, Vik, T A, Mahoney, M J, Ritchey, A K Prenatal diagnosis of beta-thalassemias by amniocentesis: linkage analysis using multiple polymorphic restriction endonuclease sites.. Blood, 56(5), 926-30, 1980.
- Phillips, J A Prenatal diagnosis of sickle cell anemia and beta-thalassemia by amniocentesis.. Tex Rep Biol Med, 40261-72, 1980.
You do not have JavaScript enabled. This site works better with JavaScript turned on.

